The Human Cytomegalovirus UL97 Protein Kinase, an Antiviral Drug Target, Is Required at the Stage of Nuclear Egress
Human cytomegalovirus encodes an unusual protein kinase, UL97, that activates the established antiviral drug ganciclovir and is specifically inhibited by a new antiviral drug, maribavir. We used maribavir and a UL97 null mutant, which is severely deficient in viral replication, to determine what sta...
שמור ב:
| הוצא לאור ב: | J Virol |
|---|---|
| Principais autores: | , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
American Society for Microbiology (ASM)
2003
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC140798/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/12502806/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/JVI.77.2.905-914.2003 |
| תגים: |
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|
